Topical Analgesic Artridon Recalled Due to Manufacturing Defects
Artridon topical analgesic has been recalled due to manufacturing practice deviations. The recall affects 9,984 tubes distributed in Delaware and North Carolina and was initiated by the manufacturer.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This Class II voluntary recall identifies manufacturing practice deviations without specifying a particular health hazard or reporting any illnesses or injuries. Per the severity rubric, voluntary precautionary recalls without reported harm are classified as Moderate.
Plain-English summary
Artridon Glucosamine (menthol 2% and methyl salicylate 15%), a topical analgesic for arthritis joint pain relief, has been recalled due to current Good Manufacturing Practice (CGMP) deviations. The affected product is the 5 oz (142g) tube formulation, NDC 55758-030-05.
The recall affected 9,984 tubes distributed in Delaware and North Carolina. The affected lot is SP25A with an expiration date of September 30, 2026. The product is manufactured by Kenil Healthcare Private Limited in India and distributed by Pharmadel LLC of New Castle, Delaware.
The manufacturer voluntarily initiated this recall on April 24, 2025, and the recall was completed on February 19, 2026. Consumers in possession of this product should stop using it and may contact the manufacturer or their pharmacist for proper disposal instructions.
The recalled product
- Product
- ARTRIDON (MENTHOL, METHYL SALICYLATE)
- Brand
- ARTRIDON
- Manufacturer
- KENIL HEALTHCARE PRIVATE LIMITED
- Category
- Drug — Topical Analgesic
- Hazard
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot SP25A
- Exp Date: 09/30/2026
UPCs (1)
- 810096771513
Distribution
Distributed in 2 states:
- DE
- NC
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27